NO913786L - Fremgangsmaate for fremstilling av fibrinogenreseptorantagonister. - Google Patents

Fremgangsmaate for fremstilling av fibrinogenreseptorantagonister.

Info

Publication number
NO913786L
NO913786L NO91913786A NO913786A NO913786L NO 913786 L NO913786 L NO 913786L NO 91913786 A NO91913786 A NO 91913786A NO 913786 A NO913786 A NO 913786A NO 913786 L NO913786 L NO 913786L
Authority
NO
Norway
Prior art keywords
fibrinogene
procedure
manufacturing
receptor antagonists
antagonists
Prior art date
Application number
NO91913786A
Other languages
English (en)
Norwegian (no)
Other versions
NO913786D0 (no
Inventor
Mark E Duggan
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO913786D0 publication Critical patent/NO913786D0/no
Publication of NO913786L publication Critical patent/NO913786L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO91913786A 1990-09-27 1991-09-26 Fremgangsmaate for fremstilling av fibrinogenreseptorantagonister. NO913786L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58928290A 1990-09-27 1990-09-27

Publications (2)

Publication Number Publication Date
NO913786D0 NO913786D0 (no) 1991-09-26
NO913786L true NO913786L (no) 1992-03-30

Family

ID=24357362

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91913786A NO913786L (no) 1990-09-27 1991-09-26 Fremgangsmaate for fremstilling av fibrinogenreseptorantagonister.

Country Status (15)

Country Link
EP (1) EP0479481A3 (fi)
JP (1) JPH0517498A (fi)
KR (1) KR920006373A (fi)
CN (1) CN1060293A (fi)
AU (1) AU8477891A (fi)
CA (1) CA2052057A1 (fi)
CS (1) CS294791A3 (fi)
FI (1) FI914532A (fi)
HU (1) HUT60751A (fi)
IE (1) IE913380A1 (fi)
IL (1) IL99539A0 (fi)
MX (1) MX9101311A (fi)
NO (1) NO913786L (fi)
PT (1) PT99095A (fi)
ZA (1) ZA917695B (fi)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5939412A (en) * 1992-06-26 1999-08-17 Smithkline Beecham Corporation Bicyclic fibrinogen antagonists
ZA924760B (en) * 1991-06-28 1993-03-31 Smithkline Beecham Corp Bicyclic fibrinogen antagonists
US5340798A (en) * 1992-10-14 1994-08-23 Merck & Co., Inc. Fibrinogen receptor antagonists
ATE188379T1 (de) * 1992-10-14 2000-01-15 Merck & Co Inc Fibrinogenrezeptor-antagonisten
AU674553B2 (en) * 1992-10-14 1997-01-02 Merck & Co., Inc. Fibrinogen receptor antagonists
US5358956A (en) * 1992-10-14 1994-10-25 Merck & Co., Inc. Fibrinogen receptor antagonists
AU675689B2 (en) * 1992-12-01 1997-02-13 Merck & Co., Inc. Fibrinogen receptor antagonists
US5750754A (en) * 1993-03-29 1998-05-12 Zeneca Limited Heterocyclic compounds
ZW4194A1 (en) * 1993-03-29 1994-12-21 Zeneca Ltd Heterocyclic compounds
US5652242A (en) * 1993-03-29 1997-07-29 Zeneca Limited Heterocyclic derivatives
US5753659A (en) * 1993-03-29 1998-05-19 Zeneca Limited Heterocyclic compouds
DE69411900T2 (de) * 1993-03-29 1998-12-10 Zeneca Ltd., London Heterozyklische derivate als plätchenaggregationsinhibitoren
US5334596A (en) * 1993-05-11 1994-08-02 Merck & Co., Inc. Fibrinogen receptor antagonists
US5463011A (en) * 1993-06-28 1995-10-31 Zeneca Limited Acid derivatives
GB9313285D0 (en) * 1993-06-28 1993-08-11 Zeneca Ltd Acid derivatives
GB9313268D0 (en) * 1993-06-28 1993-08-11 Zeneca Ltd Chemical compounds
US5397791A (en) * 1993-08-09 1995-03-14 Merck & Co., Inc. Fibrinogen receptor antagonists
US6274705B1 (en) 1996-05-02 2001-08-14 Aventis Pharmaceuticals Products Inc. Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
US5780590A (en) * 1993-10-15 1998-07-14 Rhone-Poulenc Rorer Pharmaceuticals Inc. Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
JP3032297B2 (ja) * 1993-10-15 2000-04-10 ローヌ‐プーラン ローラー ファーマシューティカルズ インコーポレイテッド 抗血栓性アザシクロアルキルアルカノイルペプチド及びプソイドペプチド
MA23420A1 (fr) * 1994-01-07 1995-10-01 Smithkline Beecham Corp Antagonistes bicycliques de fibrinogene.
US6458784B1 (en) 1994-06-29 2002-10-01 Smithkline Beecham Corporation Vitronectin receptor antagonists
US5451578A (en) * 1994-08-12 1995-09-19 Merck & Co., Inc. Fibrinogen receptor antagonists
US5525617A (en) * 1994-08-24 1996-06-11 Merck & Co., Inc. Fibrinogen receptor antagonists
US5977101A (en) * 1995-06-29 1999-11-02 Smithkline Beecham Corporation Benzimidazoles/Imidazoles Linked to a Fibrinogen Receptor Antagonist Template Having Vitronectin Receptor Antagonist Activity
US5789421A (en) * 1995-10-26 1998-08-04 Merck & Co., Inc. Fibrinogen receptor antagonist
US5780480A (en) * 1996-02-28 1998-07-14 Merck & Co., Inc. Fibrinogen receptor antagonists
KR100512671B1 (ko) * 1996-11-27 2005-09-07 아벤티스 파마슈티칼스 인크. 항 Ｘａ 활성을 지닌 화합물 및 혈소판 응집 길항제 화합물을포함하는 약제학적 조성물
EP1747219A4 (en) * 2004-05-13 2010-05-26 Glaxo Group Ltd Antagonists of muscarinic acetylcholine receptor

Also Published As

Publication number Publication date
NO913786D0 (no) 1991-09-26
EP0479481A2 (en) 1992-04-08
CA2052057A1 (en) 1992-03-28
JPH0517498A (ja) 1993-01-26
PT99095A (pt) 1992-08-31
AU8477891A (en) 1992-04-02
KR920006373A (ko) 1992-04-27
FI914532A0 (fi) 1991-09-26
IE913380A1 (en) 1992-04-08
HUT60751A (en) 1992-10-28
CN1060293A (zh) 1992-04-15
MX9101311A (es) 1992-05-04
IL99539A0 (en) 1992-08-18
FI914532A (fi) 1992-03-28
CS294791A3 (en) 1992-04-15
EP0479481A3 (en) 1993-07-28
HU913074D0 (en) 1992-01-28
ZA917695B (en) 1992-05-27

Similar Documents

Publication Publication Date Title
NO913786D0 (no) Fremgangsmaate for fremstilling av fibrinogenreseptorantagonister.
FI923931A0 (fi) Anordning foer granskning av insidan av en foergrenad roerlinje.
NO912848L (no) Substituerte azoler, fremgangsmaate for fremstilling deravog anvendelse av forbindelsene.
FI913048A0 (fi) Bicykliska heterocykliska foereningar.
NO911724D0 (no) Anordning for fremstilling av foeringer.
NO894583D0 (no) Fremgangsmaate for fremstilling av celleplast.
NO910200D0 (no) Fremgangsmaate for fremstilling av polypeptider.
TR199501389A2 (tr) Adesyon reseptörü antagonistleri (karsitlari).
NO904222L (no) Fremgangsmaate for fremstilling av benzodiazepiner.
NO903513D0 (no) Fremgangsmaate for fremstilling av cykliske neurokinin a-antagonister.
NO911368L (no) Fremgangsmaate for fremstilling av 2-substituerte alkyl-3-karboksy-karbapenemer.
NO894762D0 (no) Fremgangsmaate for bygging av hengebro.
NO910649D0 (no) Fremgangsmaate til fremstilling av staurosporin.
NO904061D0 (no) Fremgangsmaate for fremstilling av nmda-antagonister.
NO910181D0 (no) Fremgangsmaate for alkylering av hydrokinon.
NO910894L (no) Fremgangsmaate til fremstilling av cefalosporin.
FI930108A (fi) Imidazopyridin-paf-antagonister
DE69004827D1 (de) Alpha-adrenergene Rezeptor-Antagonisten.
NO901315L (no) Fremgangsmaate for fremstilling av modifisert pe40.
FI924789A (fi) Gamma-interferoners loesliga, stympade receptor
NO904732D0 (no) Fremgangsmaate for fremstilling av syntetisk wollastonitt.
MX9203694A (es) Antagonistas de receptores de angiotensina ii.
NO914563D0 (no) Fremgangsmaate for fremstilling av 3h-puriner
FI905096A (fi) Anordning foer flyttning av bytbart flak.
NO911480D0 (no) Fremgangsmaate for fremstilling av byggekomponenter.